Accretion Therapeutics, Inc. — Form D

Accretion Therapeutics, Inc. of LINCOLNSHIRE, IL, a company, filed a Form D exempt-offering notice with the SEC on 2026-02-17. The offering totals $1.0M, of which $750K was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2026-02-17
• Form: D
• Accession: 0002109293-26-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $1.0M
• Amount sold: $750K
• Remaining: $250K
• Minimum investment: $750K
• Investors: 1
• Date of first sale: 2026-02-04
• Revenue range: Decline to Disclose
• SEC file number: 021-573655

Issuer

• Name: Accretion Therapeutics, Inc.
• CIK: 0002109293
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2026
• Address: 416 OLD MILL CIR, LINCOLNSHIRE, IL, 60069
• Phone: 8473233236

Officers, directors & promoters (2)

More

• CIK 2109293 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search